Anthropometric Measurements as Predictors of Low Birth Weight Among Tanzanian Neonates: A Hospital-Based Study
November 7, 2025
Brand Name :
Depen, Cuprimine, D-Penamine
Synonyms :
penicillamine
Class :
Antirheumatic, Chelator
Dosage Forms & Strengths
Tablet
250mg
Capsule
125mg
250mg
1-1.5g every day orally or divided twice or thrice a day for 1-6 months
100mg/kg/day orally divided every 6 hours for five days
Initial dose:125-250mg/day orally
Maintenance dose: If there is no improvement and the patient tolerates it, the dose may be increased by an additional 125–250 mg every 1-3 months, up to 500–750 mg daily
Off-label:
250 - 500
mg/day
dose divided every 6 hours
The dosage may be increased gradually over time to a maximum of 1,500 mg per day, depending on the patient's response
Dosage Forms & Strengths
Tablet
250mg
Capsule
125mg
250mg
20-40 mg/kg every day orally divided every 8 hours
1st step(For two months): 5 mg/kg orally every day for two months
2nd step(For four months): 10 mg/kg orally every day for four months
Refer adult dosing
may have an increased immunosuppressive effect when combined with disease-modifying antirheumatic drugs (DMARDS)
When penicillamine is used together with ouabain, this leads to reduction in penicillamine excretion
dried ferrous sulfate / sodium ascorbate
causes a significant reduction in the gastrointestinal absorption of penicillamine
may have an increased immunosuppressive effect when combined with disease-modifying antirheumatic drugs
dried ferrous sulfate/folic acid
causes a significant reduction in the gastrointestinal absorption of penicillamine
May enhance the toxic effects of the other by pharmacodynamic synergism
May enhance the toxic effects of the other by pharmacodynamic synergism
May enhance the toxic effects of the other by pharmacodynamic synergism
May enhance the toxic effects of the other by pharmacodynamic synergism
May enhance the toxic effects of the other by pharmacodynamic synergism
Actions and Spectrum:
Frequency defined
>10%
Worsening neurologic symptoms
Adverse effects indicating therapy discontinuation
Taste alteration (12%)
Discontinued in 20-30% of pts with Wilson’s disease
Diarrhea (17%)
1-10%
Rash(<5%)
Leukopenia(2-5%)
Proteinuria (6%)
Thrombocytopenia (4-5%)
Frequency not defined
Goodpasture’s syndrome
Neuropathy
Oral lichenoid reaction
Optic neuritisTinnitus
Positive ANA
Hepatitis
Pancreatitis
Hemolytic anemia
Anorexia
Myasthenia gravis
Nausea/vomiting
Fever
Contraindications/caution:
Contraindications:
Caution:
Pregnancy consideration: penicillamine is not recommended during pregnancy due to the potential risks to the developing fetus or infant.
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology:
Pharmacodynamics:
Pharmacokinetics:
Absorption
penicillamine is rapidly absorbed from the gastrointestinal tract when taken orally, with peak plasma concentrations achieved within 1 to 2 hours after administration.
Distribution
penicillamine is distributed widely throughout the body, including the liver, kidney, and brain. The medication can cross the blood-brain barrier and the placenta and is excreted into breast milk.
Metabolism
penicillamine is not metabolized to a significant extent in the body.
Elimination and Excretion
penicillamine is primarily excreted unchanged in the urine. The medication has a short half-life of approximately 1 to 2 hours and is rapidly eliminated from the body.
Administration:
penicillamine is typically administered orally in the form of a tablet or capsule. It is usually taken on an empty stomach one hour before or two hours after meals to maximize its absorption
Patient information leaflet
Generic Name: penicillamine
Pronounced: [ pen-ih-SILL-ah-meen ]
Why do we use penicillamine?
penicillamine is sometimes used for the treatment of mercury poisoning. when mercury enters the body, it binds to sulfhydryl groups, which are present in many proteins and enzymes. penicillamine contains a sulfhydryl group that can compete with the mercury for binding sites, allowing it to bind to the mercury instead. Once penicillamine has bound to the mercury, it can form a stable complex that is more easily excreted by the kidneys.
Penicillamine is not always the first-line treatment for mercury poisoning, and its use depends on the severity of the poisoning, as well as the patient’s overall health and medical history.
penicillamine is primarily used for the treatment of a few specific conditions, including: